Bio-Techne
TECH
#1533
Rank
A$17.09 B
Marketcap
$107.62
Share price
2.24%
Change (1 day)
11.09%
Change (1 year)
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.

EPS for Bio-Techne (TECH)

EPS in 2023 (TTM): $2.36

According to Bio-Techne's latest financial reports the company's current EPS (TTM) is $2.40. In 2022 the company made an earnings per share (EPS) of $2.56 an increase over its 2021 EPS that were of $2.06.

EPS history for Bio-Techne from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$2.36-7.75%
2022$2.5624.35%
2021$2.0617.98%
2020$1.75-10.94%
2019$1.96101.57%
2018$0.97-17.53%
2017$1.1839.37%
2016$0.85-17.23%
2015$1.02-14.97%
2014$1.201.29%
2013$1.193.68%
2012$1.14-1.97%
2011$1.171.67%
2010$1.157.14%
2009$1.07-1.06%
2008$1.0819.41%
2007$0.9119.1%
2006$0.7610.56%
2005$0.6929.5%
2004$0.5313.05%
2003$0.4768.43%
2002$0.28-17.05%
2001$0.3417.33%
2000$0.2948.51%
1999$0.1923.17%
1998$0.1613.89%
1997$0.1442.57%
1996$0.09669

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$23.50 877.07%๐Ÿ‡บ๐Ÿ‡ธ USA
-$8.76-464.33%๐Ÿ‡บ๐Ÿ‡ธ USA
$8.50 253.50%๐Ÿ‡บ๐Ÿ‡ธ USA
$12.28 410.83%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.23-7.38%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
$13.10 444.59%๐Ÿ‡บ๐Ÿ‡ธ USA
-$1.44-159.87%๐Ÿ‡บ๐Ÿ‡ธ USA